Predictive performance of the Domino, Hijazi, and Clements models during low-dose target-controlled ketamine infusions in healthy volunteers.
BACKGROUND
Healthy volunteers received low-dose target-controlled infusions (TCI) of ketamine controlled by the Domino model while cognitive function tests and functional neuroimaging were performed. The aim of the current study was to assess the predictive performance of the Domino model during these studies, and compare it with that of three other ketamine models.


METHODS
Fifty-eight volunteers received ketamine administered by a TCI device on one or more occasions at target concentrations of either 50, 100, or 200 ng ml-1. At each target concentration, two or three venous blood samples were withdrawn during infusion, with a further sample after the infusion ended. Ketamine assays were performed by gas chromatography. The plasma concentration time courses predicted by the Hijazi, Clements 125, and Clements 250 models were calculated retrospectively, and the predictive performance of each of the models was assessed using Varvel methodology.


RESULTS
For the Domino model, bias, inaccuracy, wobble, and divergence were - 2.7%, 33.9%, 24.2%, and 0.1463% h-1, respectively. There was a systematic increase in performance error over time. The Clements 250 model performed best by all criteria, whereas the Hijazi model performed least well by all criteria except for bias.


CONCLUSIONS
Performance of the Domino model during control of low-dose ketamine infusions was sub-optimal. The Clements 250 model may be a better model for controlling low-dose TCI ketamine administration.
Absalom
A R
AR
University Division of Anaesthesia, Addenbrooke's Hospital, and University of Cambridge School of Clinical Medicine, CB2 2QQ, UK. ara30@wbic.cam.ac.uk
Lee
M
M
Menon
D K
DK
Sharar
S R
SR
De Smet
T
T
Halliday
J
J
Ogden
M
M
Corlett
P
P
Honey
G D
GD
Fletcher
P C
PC
D000293:Adolescent; D000328:Adult; D000778:Anesthetics, Dissociative / Q000008:administration & dosage* / Q000097:blood; D003071:Cognition / Q000187:drug effects; D004334:Drug Administration Schedule; D016503:Drug Delivery Systems; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007649:Ketamine / Q000008:administration & dosage* / Q000097:blood; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D009483:Neuropsychological Tests; D011237:Predictive Value of Tests; D011446:Prospective Studies
D000778:Anesthetics, Dissociative; D007649:Ketamine